TherapeuticsMD Names Joel S. Krasnow, M.D. as Chief Scientific Officer

TherapeuticsMD TXMD announced today the appointment of Joel S. Krasnow, M.D., M.B.A., a leading board-certified OB/GYN and reproductive endocrinologist with broad biotech and pharmaceutical experience, as the Company's Chief Scientific Officer and head of its regulatory department. Dr. Krasnow's career spans 15 years in the pharmaceutical industry, including several global product registrations in women's health and related areas. He began his career in academic medicine where he received funding for both basic science and clinical research in women's health. During his time in academic medicine, Dr. Krasnow served as the Principal Investigator on a number of menopause clinical trials See full press release